Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 407, Issue 4, 2011, Pages 831-836

  Ryu, Kwanghee ^a   Park, Choa ^a   Lee, YoungJoo ^a  

^a Sejong University   (South Korea)

Author keywords

ESR1 gene; Estrogen; Estrogen receptor; Hypoxia

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; RNA POLYMERASE II;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL STRAIN T47D; CONTROLLED STUDY; DOWN REGULATION; ENDOMETRIUM CELL; FEMALE; GENE CONTROL; GENE LOCUS; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYPOXIA; ISHIKAWA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CELL HYPOXIA; DOWN-REGULATION; ENDOMETRIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TUMOR MICROENVIRONMENT;

EID: 79955033732     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.03.119     Document Type: Article

References (24)

1. Chaudary N., Hill R.P. Hypoxia and metastasis in breast cancer. Breast Dis. 2007, 26:55-64.
2. Ueki T., Park J., Nishidate T., Kijima K., Hirate K., Nakamura Y., Katagiri T. Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 2009, 69:8752-8760.
3. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA-Cancer J. Clin. 2005, 55:74-108.
4. Powers G.L., Ellison-Zelski S.J., Casa A.J., Lee A.V., Alarid E.T. Proteasome inhibition represses ER alpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer. Oncogene 2010, 29:1509-1518.
5. Fox E.M., Davis R.J., Shupnik M.A. ER beta in breast cancer-onlooker, passive player, or active protector?. Steroids 2008, 73:1039-1051.
6. Liu H., Qiu J., Li N., Chen T., Cao X. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ER alpha) in human cancer cells by inhibiting proteasome-dependent ER alpha degradation via association with Src. J. Biol. Chem. 2010, 285:21934-21942.
7. Fowler A.M., Alarid E.T. Amping up estrogen receptors in breast cancer. Breast Cancer Res. 2007, 9:305.
8. Leu Y.W., Yan P.S., Fan M., Jin V.X., Liu J.C., Curran E.M., Welshons W.V., Wei S.H., Davuluri R.V., Plass C., Nephew K.P., Huang T.H. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res. 2004, 64:8184-8192.
9. Skliris G.P., Leygue E., Watson P.H., Murphy L.C. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. J. Steroid Biochem. 2008, 109:1-10.
10. Massarweh S., Schiff R. Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. Endocr. Relat. Cancer 2006, 1:S15-24.
11. Brahimi-Horn M.C., Pouysségur J. Oxygen, a source of life and stress. FEBS Lett. 2007, 581:3582-3591.
12. Brahimi-Horn M.C., Chiche J., Pouysségur J. Hypoxia and cancer. J. Mol. Med. 2007, 85:1301-1307.
13. Santhanam A.N., Baker A.R., Hegamyer G., Kirschmann D.A., Colburn N.H. Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion. Oncogene 2010, 29:3921-3932.
14. Yamamoto Y., Ibusuki M., Okumura Y., Kawasoe T., Kai K., Iyama K., Iwase H. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer. Breast Cancer Res. Tr. 2008, 110:465-475.
15. Trastour C., Benizri E., Ettore F., Ramaioli A., Chamorey E., Pouysségur J., Berra E. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int. J. Cancer 2007, 120:1451-1458.
16. Coradini D., Pellizzaro C., Speranza A., Daidone M.G. Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens. Cell. Mol. Life Sci. 2004, 61:76-82.
17. Kimbro K.S., Simons J.W. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr. Relat. Cancer 2006, 13:739-749.
18. Bos R., van Diest P.J., van der Groep P., Shvarts A., Greijer A.E., van der Wall E. Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res. 2004, 6:R450-R459.
19. Cho J., Kim D., Lee S., Lee Y. Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. Mol. Endocrinol. 2005, 19:1191-1199.
20. Stoner M., Saville B., Wormke M., Dean D., Burghardt R., Safe S. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol. Endocrinol. 2002, 16:2231-2242.
21. Ellison-Zelski S.J., Solodin N.M., Alarid E.T. Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter. Mol. Cell Biol. 2009, 29:4949-4958.
22. Mole D.R., Blancher C., Copley R.R., Pollard P.J., Gleadle J.M., Ragoussis J., Ratcliffe P.J. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J. Biol. Chem. 2009, 284:16767-16775.
23. Ortiz-Barahona A., Villar D., Pescador N., Amigo J., del Peso L. Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction. Nucleic Acids Res. 2010, 38:2332-2345.
24. Elvidge G.P., Glenny L., Appelhoff R.J., Ratcliffe P.J., Ragoussis J., Gleadle J.M. Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways. J. Biol. Chem. 2006, 281:15215-15226.